ALKS
ALKS
NASDAQ · Biotechnology

Alkermes Plc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$44.18
+0.79 (+1.82%)
As of Sep 21, 9:52 PM ET ·
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 19 76%
Hold 5 20%
Sell 1 4%
Price Target
Analyst Price Target +186.1% upside
Low Target $90.34
Average Target $126.40
High Target $146.79
Current Price $44.18
Current
$44.18
Target
$126.40
$90.34 $126.40 avg $146.79
Scenario Analysis
Bear Case
$90.34
104.5%
Low target
Base Case
$126.40
+186.1%
Avg target
Bull Case
$146.79
+232.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$55.67
-20.6% from high
52-Week Low
$26.99
+63.7% from low
50-Day SMA
$31.02
+42.4% vs SMA
200-Day SMA
$29.87
+47.9% vs SMA
RSI (14)
32.3
Neutral
Target vs 52W High
$126.40
+127.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%